Zobrazeno 1 - 10
of 236
pro vyhledávání: '"Jutta K Preiksaitis"'
Publikováno v:
Microorganisms, Vol 12, Iss 4, p 742 (2024)
Development of a vaccine for human cytomegalovirus (hCMV) is critical because of the severe consequences of infection in congenitally infected newborns and immunocompromised patients. The assessment of hCMV-neutralizing antibody activity is crucial f
Externí odkaz:
https://doaj.org/article/9c417982be09430f9a83981eaaaf2374
Autor:
Ryan J. Stubbins, Ryan Lam, James Zhu, Sunita Ghosh, Curtis Mabilangan, John Kuruvilla, Rashmi S Goswami, Raymond Lai, Jutta K Preiksaitis, Michael D Jain, Anthea C Peters
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:744-752
The tumor microenvironment (TME) in post-transplant lymphoproliferative disorders (PTLDs) remains unexplored. Tumor infiltrating lymphocytes (TILs) are prognostic in other lymphomas. We assessed the prognostic impact of TILs in monomorphic B-cell PTL
Autor:
Cristina Hernandez, Curtis Mabilangan, Catherine Burton, Jutta K. Preiksaitis, Karen Doucette
Publikováno v:
American Journal of Transplantation. 21:3958-3970
Although antiviral prophylaxis has reduced cytomegalovirus (CMV) DNAemia and disease in seronegative solid organ transplant (SOT) recipients (R-) receiving seropositive donor organs (D+), its impact on CMV transmission is uncertain. Transmission, def
Autor:
Bruno Fernando Buzo, Jutta K. Preiksaitis, Kieran Halloran, Jayan Nagendran, Derek R. Townsend, Nathan Zelyas, Wendy I. Sligl
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation SocietyREFERENCES.
Hyperammonemia syndrome (HS) is a rare post-transplant complication associated with high morbidity and mortality. Its incidence appears to be higher in lung transplant recipients and its pathophysiology is not well understood. In addition to underlyi
Autor:
Clayton MacDonald, Ryan Cooper, Alessandro Massolo, Stan Houston, Kinga Kowalewska-Grochowska, Norbert Müller, Bruno Gottstein, Jutta K. Preiksaitis, Philippe Sarlieve, Klaus Buttenschoen, Safwat Girgis, Gavin Low, Sara Belga, Stephen Vaughan
Publikováno v:
Am J Trop Med Hyg
Human alveolar echinococcosis (AE) is a zoonotic cestode infection which is usually fatal in the absence of treatment. Treatment involves major surgery or indefinite antiparasitic therapy. The incidence is rising in Europe and Asia, with an increased
Autor:
Catherine Burton, Jutta K. Preiksaitis, Sheila F. O'Brien, Curtis Mabilangan, Susan Nahirniak
Publikováno v:
American Journal of Transplantation. 20:3509-3519
Solid organ transplant (SOT) recipients who are cytomegalovirus (CMV) seronegative (R-) and receive seronegative donor (D-) organs have a small but currently unquantified risk of both transfusion-transmitted CMV (TT-CMV) and community-acquired CMV (C
Autor:
Jutta K. Preiksaitis, Curtis Mabilangan, Sabrina Plitt, Catherine Burton, Sheila F. O'Brien, Dean T. Eurich
Publikováno v:
J Assoc Med Microbiol Infect Dis Can
Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections are common, causing significant morbidity in pregnancy (congenital CMV) and transplant recipients (CMV, EBV). Canadian prevalence data are needed to model disease burden and develop strate
Publikováno v:
The Journal of Infectious Diseases. 223:827-837
Background The epidemiology of single versus multiple cytomegalovirus (CMV) strain transmission from donor (D+) to seronegative solid organ transplant (SOT) recipients (R−) is uncertain, as is whether “relapsing” recipient infection represents
Autor:
Jutta K. Preiksaitis, Simon Urschel, Catherine Burton, Martina Sester, Joan L. Robinson, Dean T. Eurich
Publikováno v:
Journal of Clinical Virology. 115:37-42
Background/objectives: Determination of Cytomegalovirus (CMV) status in solid organ transplant (SOT) candidates is essential to stratify risk of post-transplant CMV disease. Passive transfusion-acquired antibodies can make serologic determination of
Autor:
Catherine Burton, Jutta K. Preiksaitis
Publikováno v:
Post-Transplant Lymphoproliferative Disorders ISBN: 9783030654023
Tests quantitatively measuring Epstein-Barr virus (EBV) DNA in peripheral blood are an important component of strategies for post-transplant lymphoproliferative disorder (PTLD) prevention, diagnosis, and management. This chapter summarizes current kn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22182b97230bd128af5443abd4ab7396
https://doi.org/10.1007/978-3-030-65403-0_6
https://doi.org/10.1007/978-3-030-65403-0_6